课题基金 / 基金详情

Real-time PCR expression profiling of microRNA

Real-time PCR expression profiling of microRNA
microRNA 的实时 PCR 表达谱
批准号:
7137111
负责人:
THOMAS D. SCHMITTGEN
金额:
$21.02万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-09-25 至 2008-05-31

项目摘要

项目成果

THOMAS D. SCHMITTGEN的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): microRNA is a newly discovered class of endogenous, small interfering RNA. MicroRNA binds to messenger RNA and translationally represses protein levels. While over 300 microRNAs have been discovered in humans alone, their biological function, targets, expression levels and role in disease remain largely unknown. A role between microRNA expression and carcinogenesis has been proposed. There is a lack of sensitive, high-throughput methodologies to monitor the expression of microRNAs. microRNA are challenging molecules to quantify because the microRNA precursors consists as a stable hairpin and the mature microRNA is only 22 nucleotides in length. We propose to evaluate sensitive and specific real-time PCR assays to quantify the expression of the mature and microRNA precursors. The microRNA expression will be analyzed in a number of important biological conditions relating to human cancer. The microRNA expression will be determined in specific sections of cancer and normal tissue isolated by laser-capture microdissection. The expression of mature and precursor microRNAs will be compared to using real-time PCR and a cDNA micro array. microRNA expression will be studied in clinical samples of human pancreatic cancer. The unparallel sensitivity and specificity of real-time PCR as applied to this new and exciting class of regulatory RNAs should propel the field into new directions not only in cancer but in other areas of human health.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1111/j.1582-4934.2008.00483.x
发表时间: 2008-10
期刊: Journal of cellular and molecular medicine
影响因子: 5.3
作者: [Schmittgen TD]
通讯作者: Schmittgen TD
DOI: 10.1158/0008-5472.can-11-1144
发表时间: 2011-12-15
期刊: Cancer research
影响因子: 11.2
作者: [Park JK, Kogure T, Nuovo GJ, Jiang J, He L, Kim JH, Phelps MA, Papenfuss TL, Croce CM, Patel T, Schmittgen TD]
通讯作者: Schmittgen TD
DOI: 10.2144/000113068
发表时间: 2009-02
期刊: BioTechniques
影响因子: 2.7
作者: [Nuovo G, Lee EJ, Lawler S, Godlewski J, Schmittgen T]
通讯作者: Schmittgen T
DOI: 10.1016/j.bbrc.2011.02.065
发表时间: 2011-03-25
期刊: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
影响因子: 3.1
作者: [Park, Jong-Kook, Henry, Jon C., Jiang, Jinmai, Esau, Christine, Gusev, Yuriy, Lerner, Megan R., Postier, Russell G., Brackett, Daniel J., Schmittgen, Thomas D.]
通讯作者: Schmittgen, Thomas D.
7
    R21 MPI microRNA directed therapy for treating early stage pancreatic cancer
    • 批准号:
      10577609
    • 项目类别:
    • 资助金额:
      $17.82万
    • 财政年份:
      2023
    • 负责人:
      THOMAS D. SCHMITTGEN
    • 依托单位:
    Pilot Project 3: Contribution of Racial Disparity towards the Early Development of Pancreatic Cancer
    • 批准号:
      10006214
    • 项目类别:
    • 资助金额:
      $11.3万
    • 财政年份:
      2018
    • 负责人:
      THOMAS D. SCHMITTGEN
    • 依托单位:
    Project 3 ADM
    • 批准号:
      10762126
    • 项目类别:
    • 资助金额:
      $11.6万
    • 财政年份:
      2018
    • 负责人:
      THOMAS D. SCHMITTGEN
    • 依托单位:
    miRNA Biomarkers for Hepatocellular Carcinoma Associated with Viral Hepatitis
    • 批准号:
      8520269
    • 项目类别:
    • 资助金额:
      $16.77万
    • 财政年份:
      2012
    • 负责人:
      THOMAS D. SCHMITTGEN
    • 依托单位:
    国内基金
    海外基金
    靶向Human ZAG蛋白的降糖小分子化合物筛选以及疗效观察
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      胡文静
    • 依托单位:
    新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
    • 批准号:
      82370885
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      姚晨
    • 依托单位:
    自闭症相关基因CHD8在非人灵长类大脑发育中的作用
    HBV S-Human ESPL1融合基因在慢性乙型肝炎发病进程中的分子机制研究
    • 批准号:
      81960115
    • 项目类别:
      地区科学基金项目
    • 资助金额:
      34.0万元
    • 批准年份:
      2019
    • 负责人:
      江建宁
    • 依托单位: